EUVIMEDEUVIMED entdecken
Crossref

Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals

Aimei Ye, Dan Zhang, Xu Liu, Lihua Xu, Yanyan Wei, Huiru Cui, Wensi Zheng, Yawen Hong, Jinyang Zhao, Yingying Tang, Min Su, Yong Ye und 3 weitere

Schizophrenia Research · 2025

DOI: 10.1016/j.schres.2025.09.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research, 2025. Verfasst von Aimei Ye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Ningde Rehabilitation Hospital, Ningde, China. Hauptthemen laut MEDLINE: Antipsychotic Agents, Eye Movements, Schizophrenia, Ocular Motility Disorders. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While antipsychotic-induced eye movement alterations are well-documented in schizophrenia, their effects during the clinical high-risk (CHR) phase remain uncharacterized. This study examined the effects of two-month antipsychotic treatment on eye movement parameters in CHR individuals and their association with clinical outcome. METHODS: In this longitudinal cohort, 139 CHR individuals and 105 healthy controls completed baseline eye-tracking (fixation stability, free viewing, and smooth pursuit). CHR participants were reassessed at two months and followed for three years to track remission status. Linear mixed-effects models examined the effects of antipsychotic use, dose, and type on eye movement indicators, and a random forest model evaluated how changes in these indicators predicted clinical remission. RESULTS: In the antipsychotic - treated subgroup, fixation stability featured more microsaccades, free viewing showed reduced saccade amplitude and velocity, and smooth pursuit showed increased velocity gain with reduced saccade amplitude, and these changes scaled with dose and varied by agent with the most pronounced effects for aripiprazole. A random forest classifier using two treatment-induced eye movement change values predicted 3-year clinical non-remission with an area under the receiver operating characteristic curve of 0.80. CONCLUSIONS: Short-term antipsychotic exposure induced mixed eye movement alterations that were associated with non-remission at three-year follow-up. This finding provides a reference for the development of personalized risk stratification frameworks and targeted intervention strategies in CHR populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsEye MovementsSchizophreniaOcular Motility DisordersHumansMaleFemaleAdultYoung AdultLongitudinal StudiesAdolescentSaccadesRiskEye-Tracking TechnologyProdromal Symptoms

Stichwörter der Autor:innen

AntipsychoticsEye movementProdromal psychosisRemissionUltra high risk

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Ningde Rehabilitation Hospital, Ningde, China.
  • Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
  • Ningde Rehabilitation Hospital, Ningde, China. Electronic address: 1098869406@qq.com.
  • Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China. Electronic address: zhang_tianhong@126.com.
  • Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; Center for Excellence in Brain Science and Intelligence Technology (CE…

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Ye, A., Zhang, D., Liu, X., Xu, L., Wei, Y., Cui, H., Zheng, W., Hong, Y., Zhao, J., Tang, Y., Su, M., Ye, Y., Huang, Y., Zhang, T., & Wang, J. (2025). Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals. Schizophrenia Research. https://doi.org/10.1016/j.schres.2025.09.024

Vancouver

Ye A, Zhang D, Liu X, Xu L, Wei Y, Cui H, et al. Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals. Schizophrenia Research. 2025. doi:10.1016/j.schres.2025.09.024

BibTeX
@article{Ye2025,
  author = {Ye, Aimei and Zhang, Dan and Liu, Xu and Xu, Lihua and Wei, Yanyan and Cui, Huiru and Zheng, Wensi and Hong, Yawen and Zhao, Jinyang and Tang, Yingying and Su, Min and Ye, Yong and Huang, Yingli and Zhang, Tianhong and Wang, Jijun},
  title = {Two-month antipsychotic exposure induces domain-specific eye movement alterations in clinical high-risk individuals},
  journal = {Schizophrenia Research},
  year = {2025},
  doi = {10.1016/j.schres.2025.09.024}
}
Kostenlos starten →